Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nacalai Tesque
Kyoto, Kyoto, Japannacalai.co.jp ↗
- Ownership
- Private
- Employees
- ~331
- Development stage
- Other
01
Overview
Nacalai Tesque manufactures and markets research reagents, biochemicals, diagnostics products, HPLC columns, and cell culture media. Their products support applications in molecular biology, proteomics, cell biology, diagnostics, analytical chemistry, and drug development. Recently, the company developed and marketed a cell medium for the differentiation of iPS cells into cardiomyocytes, supporting stem cell research[3].
- Therapeutic areas
- Other
- Modalities
- Small moleculeAntibodyRecombinant proteinDiagnostic reagentCell culture media
- Industry
- Chemicals & Materials
02
Partnerships
Acts as a distributor for foreign companies seeking entry into the Japanese life science market
Beyond the preview
Go deeper on Nacalai Tesque.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nacalai Tesque.